Detalles de la búsqueda
1.
Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study.
Allergy
; 77(8): 2393-2403, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35184297
2.
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
Cancer
; 125(7): 1113-1123, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30690710
3.
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors.
J Immunother Cancer
; 10(8)2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940825
4.
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies.
Blood Adv
; 4(9): 1917-1926, 2020 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32380537
5.
Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation.
Int J Radiat Biol
; 84(5): 401-12, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18464069
6.
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.
J Clin Oncol
; 35(18): 2028-2036, 2017 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28463630
Resultados
1 -
6
de 6
1
Próxima >
>>